These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30528266)

  • 1. Zinc and p53 disrupt mitochondrial binding of HK2 by phosphorylating VDAC1.
    Xue YN; Yu BB; Li JL; Guo R; Zhang LC; Sun LK; Liu YN; Li Y
    Exp Cell Res; 2019 Jan; 374(1):249-258. PubMed ID: 30528266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol protects cardiomyocytes against anoxia/reoxygenation via dephosphorylation of VDAC1 by Akt-GSK3 β pathway.
    Tian M; Xie Y; Meng Y; Ma W; Tong Z; Yang X; Lai S; Zhou Y; He M; Liao Z
    Eur J Pharmacol; 2019 Jan; 843():80-87. PubMed ID: 30445019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation.
    Arif T; Krelin Y; Shoshan-Barmatz V
    Biochim Biophys Acta; 2016 Aug; 1857(8):1228-1242. PubMed ID: 27080741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
    Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity.
    Pastorino JG; Hoek JB; Shulga N
    Cancer Res; 2005 Nov; 65(22):10545-54. PubMed ID: 16288047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PGC1α Promotes Cisplatin Resistance in Ovarian Cancer by Regulating the HSP70/HK2/VDAC1 Signaling Pathway.
    Li Y; Kang J; Fu J; Luo H; Liu Y; Li Y; Sun L
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hexokinase 2-mediated Warburg effect is required for PTEN- and p53-deficiency-driven prostate cancer growth.
    Wang L; Xiong H; Wu F; Zhang Y; Wang J; Zhao L; Guo X; Chang LJ; Zhang Y; You MJ; Koochekpour S; Saleem M; Huang H; Lu J; Deng Y
    Cell Rep; 2014 Sep; 8(5):1461-74. PubMed ID: 25176644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaempferol impairs aerobic glycolysis against melanoma metastasis via inhibiting the mitochondrial binding of HK2 and VDAC1.
    Zheng X; Pan Y; Yang G; Liu Y; Zou J; Zhao H; Yin G; Wu Y; Li X; Wei Z; Yu S; Zhao Y; Wang A; Chen W; Lu Y
    Eur J Pharmacol; 2022 Sep; 931():175226. PubMed ID: 36007607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen kringle 5 induces endothelial cell apoptosis by triggering a voltage-dependent anion channel 1 (VDAC1) positive feedback loop.
    Li L; Yao YC; Gu XQ; Che D; Ma CQ; Dai ZY; Li C; Zhou T; Cai WB; Yang ZH; Yang X; Gao GQ
    J Biol Chem; 2014 Nov; 289(47):32628-38. PubMed ID: 25296756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico construction of HK2-VDAC1 complex and investigating the HK2 binding-induced molecular gating mechanism of VDAC1.
    Zhang D; Yip YM; Li L
    Mitochondrion; 2016 Sep; 30():222-8. PubMed ID: 27544294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell death of prostate cancer cells by specific amino acid restriction depends on alterations of glucose metabolism.
    Fu YM; Lin H; Liu X; Fang W; Meadows GG
    J Cell Physiol; 2010 Aug; 224(2):491-500. PubMed ID: 20432447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mTOR-targeted therapy: differential perturbation to mitochondrial membrane potential and permeability transition pore plays a role in therapeutic response.
    Kim JE; He Q; Chen Y; Shi C; Yu K
    Biochem Biophys Res Commun; 2014 Apr; 447(1):184-91. PubMed ID: 24704448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
    Shankar S; Srivastava RK
    Int J Oncol; 2007 Apr; 30(4):905-18. PubMed ID: 17332930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria and nucleus cross-talk: Signaling in metabolism, apoptosis, and differentiation, and function in cancer.
    Shteinfer-Kuzmine A; Verma A; Arif T; Aizenberg O; Paul A; Shoshan-Barmaz V
    IUBMB Life; 2021 Mar; 73(3):492-510. PubMed ID: 33179373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CoQ
    Hseu YC; Thiyagarajan V; Ou TT; Yang HL
    Arch Toxicol; 2018 Jan; 92(1):301-322. PubMed ID: 28918503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced expression of the voltage-dependent anion channel 1 (VDAC1) in Alzheimer's disease transgenic mice: an insight into the pathogenic effects of amyloid-β.
    Cuadrado-Tejedor M; Vilariño M; Cabodevilla F; Del Río J; Frechilla D; Pérez-Mediavilla A
    J Alzheimers Dis; 2011; 23(2):195-206. PubMed ID: 20930307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1: mapping the site of binding.
    Abu-Hamad S; Zaid H; Israelson A; Nahon E; Shoshan-Barmatz V
    J Biol Chem; 2008 May; 283(19):13482-90. PubMed ID: 18308720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial VDAC1-based peptides: Attacking oncogenic properties in glioblastoma.
    Shteinfer-Kuzmine A; Arif T; Krelin Y; Tripathi SS; Paul A; Shoshan-Barmatz V
    Oncotarget; 2017 May; 8(19):31329-31346. PubMed ID: 28412744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.
    Ghosh JC; Altieri DC
    Clin Cancer Res; 2005 Jun; 11(12):4580-8. PubMed ID: 15958644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen deprivation leads to increased carbohydrate metabolism and hexokinase 2-mediated survival in Pten/Tp53-deficient prostate cancer.
    Martin PL; Yin JJ; Seng V; Casey O; Corey E; Morrissey C; Simpson RM; Kelly K
    Oncogene; 2017 Jan; 36(4):525-533. PubMed ID: 27375016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.